Retinal Capillary Hemangioblastoma and von Hippel-Lindau Disease Retinal capillary hemangioblastomas (RCH) (also known as retinal angiomas) can be a a sign of a von Hippel-Lindau (VHL) disease although they may also be observed as an isolated entity without systemic involvement
Retinal Capillary Hemangioblastoma: A Comprehensive Review on . . . Retinal capillary hemangioblastoma (RCH) is a benign tumor that frequently appears as the first manifestation in patients with von Hippel-Lindau (VHL) disease, potentially resulting in significant vision loss Thus, recognizing and managing it promptly is crucial
Retinal Capillary Hemangioblastomas in VHL - Retina Today Successful treatment of von Hippel-Lindau (VHL) disease-associated retinal capillary hemangioblastoma (RCH) with belzutifan in a pediatric patient [published online ahead of print July 13, 2023]
New VHL Guidelines: Increase Surveillance and Treat Ocular Tumors . . . New guidelines recommend lifelong surveillance and prompt treatment for patients with retinal hemangioblastomas (RHs) in von Hippel-Lindau (VHL) disease 1 The guidelines point to opportunities to connect patients and families with genetic testing and specialized VHL care
Hemangioblastoma - Symptoms and causes - Mayo Clinic About 1 in 4 hemangioblastomas is linked to a genetic condition called von Hippel-Lindau (VHL) disease This condition occurs when a person is born with a change, also called a mutation, in the VHL gene
The clinical features and real world treatment outcomes in von Hippel . . . To present the clinical features and outcomes of treatment in von Hippel-Lindau (VHL) related retinal capillary hemangioblastoma (RCH) A retrospective interventional cohort study that included Patients who were diagnosed with VHL-related RCH from 2014 to 2024 at a tertiary referral center
Management of Von Hippel-Lindau Syndrome In conclusion, Von Hippel-Lindau syndrome is a systemic disease causing the formation of multiorgan cysts and hypervascular tumors Retinal hemangioblastomas are often the first manifestation of this syndrome and a diagnosis of VHL should be considered in all patients that present with these tumors